ALSO NOTED: Lantibio touts cystic fibrosis data; Crucell gets funds for TB vaccine; and much more...

> Orphan Pharmaceuticals and Lantibio announced positive final results from their Phase II clinical study of Moli1901, an experimental compound to treat cystic fibrosis. Release

> Crucell will receive up to $5 million from Rockville, MD-based Aeras Global TB Vaccine Foundation to support the advanced development of the candidate AdVac-based tuberculosis vaccine. Release

> Perrigo is buying Qualis, which makes OTC products, for $12 million. Report

And Finally... A new study concludes that CT screening for lung cancer doesn't save lives and leaves patients vulnerable to unnecessary surgery. Report